Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...

A biochemistry postgrad with a passion for poetry and science, Prayagraj's Shakti Dubey credits her family, teachers and her ...

By leveraging siRNA technology to treat disease fundamentally, RN1871 achieves sustained efficacy with less dosing frequency. We look forward to bringing this innovative therapy to hypertension ...

China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension: Shanghai, China Tuesday, April 22, 2025, 18:00 Hrs [IST] Ro ...

In what could be seen as a bellwether for the pharmaceutical industry's sweeping shift toward localised manufacturing—spurred ...

The following is a summary of "ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is ...

Akka Nasan ibsetti waggaa wagggaan wantoonni caccabaa dhagaa fakkaatan hawaa keessaa gara pilaaneetii keenya Dacheetti ni ...

In particular, hedge fund managers, using their vast resources and analytical capabilities, are more receptive to such ...

MM UK Sir Keer Istaarmer namoonni saala isaanii jijjiirachuun dubartii tahan dubartiidha jedhanii akka hin amanne dubbii ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...